Comparison of the effect on Hyperglycemia and the Adverse Effects among Different GLP-1 Receptor Agonists Added to Basal Insulin and between GLP-1 Receptor Agonists and Basal Insulin Versus Basal-Plus or Basal-Bolus Insulin in Type 2 Diabetes: A Meta-Analysis
Diabetes mellitus type 2 (DM2) is becoming more common in the United States and around the world, owing to rising obesity rates (approximately 40% of adult individuals in the United States). Insulin resistance, which sets the stage 4-7 years before DM type 2 is diagnosed, and insulin insufficiency, which...
Read More